Mesoblast's high-risk programs drive inflated valuation. Find out why MESO stock remains a "sell" as execution risks outweigh ...
The 88-year-old, who has been breathless in recent days and has delegated officials to read his speeches, was admitted following his morning audiences, the Vatican said.